Vyome Holdings Revenue

In the year 2025, Vyome Holdings had annual revenue of $319.71K with 24.43% growth. Vyome Holdings had revenue of $36.55K in the quarter ending December 31, 2025, a decrease of -40.50%.

Revenue (ttm)

$319.71K

Revenue Growth

+24.43%

P/S Ratio

46.32

Revenue / Employee

$22,837

Employees

Market Cap

15.51M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	319.71K	62.77K	24.43%
Dec 31, 2024	256.94K	-159.00K	-38.23%
Dec 31, 2023	415.94K	33.08K	8.64%
Dec 31, 2022	382.87K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

HIND News

2 days ago - Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026 - Business Wire
13 days ago - Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase - Business Wire
7 weeks ago - Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity - Business Wire
2 months ago - Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months - Business Wire
2 months ago - Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results - Business Wire
2 months ago - Independent Analyst Values Vyome's VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study - Business Wire
3 months ago - Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company - Business Wire
4 months ago - Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval - Business Wire

More News